Cargando…
Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents
INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic due to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes worldwide devastation. We describe the course of a patient with COVID-19 in the setting of an acquired humoral deficiency as a result of chemotherapeuti...
Autores principales: | Schend, Jason, Daniels, Phuong, Sanan, Neha, Tcheurekdjian, Haig, Hostoffer, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734533/ https://www.ncbi.nlm.nih.gov/pubmed/33354381 http://dx.doi.org/10.1177/2152656720978764 |
Ejemplares similares
-
Expedited Desensitization to Canakinumab
por: Sanan, Neha, et al.
Publicado: (2020) -
Posner-Schlossman Syndrome in Common Variable Immunodeficiency
por: Huq, Madiha, et al.
Publicado: (2020) -
A case series: Association of anaphylaxis with a significant decrease in platelet levels and possible secondary risk of thrombosis
por: Peppers, Brian P., et al.
Publicado: (2018) -
Type 1 Kounis syndrome in a patient with idiopathic anaphylaxis
por: Sandhu, Monica, et al.
Publicado: (2017) -
Beware of the caterpillar: Anaphylaxis to the spotted tussock moth caterpillar, Lophocampa maculata
por: DuGar, Brandon, et al.
Publicado: (2014)